Skip to content
★ Sign in to follow
QingSong Health Corporation logo

QingSong Health Corporation Stock: price and insider trades · Hong Kong

HK·Mcap HK$658.5M

No insider purchase over the last 90 days. The latest, by 楊胤, was filed 07 Jul 2026.

QingSong Health Corporation: what insiders have been doing

Every trade that managers of QingSong Health Corporation disclose to HKEX is tracked on this page. 1 insider has disclosed 3 filings since 8 November 2025.

The flow runs one way only: 1 insider bought (3 purchases totalling €8.2M) and nobody sold on the market. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Biggest ticket of the year: €3.3M, bought by 楊胤 and made public on 7 July 2026 (3.5% of market cap). On the buying side, the filings list 1 senior executive among the declarants.

The clock since the last published purchase (7 July 2026) now reads 124 days. Typically, a trade is published a median of 5 days after it takes place. This delay matters because a trade only becomes useful information once it is public.

Compared with its exchange (750 companies, median 5 filings), a count of 3 filings is below the norm. Looking back to 2026, when coverage begins, insiders filed 3 purchases and no sales.

Every figure here comes from the filings published by HKEX and describes the past, not future prices; it is not investment advice.

Insider Decl.
3
Thresholds
n/a
Buy Volume
€8M
3 ops. · all time
Sell Volume
n/a
n/a

Who traded when

BuySale
楊胤3 buys

Since the insiders bought

  • Filed 07 Jul 2026 · 124 days ago · €3.0M
    -58.2%
    Entry HK$8.38 · Close at T+90 HK$3.50

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.

Fundamental score
Ranked 13,078 of 26,897 companies
52.1
score / 100
Value
53
Quality
52
FCF yld13%
Earn yld-61%
EV/EBITDA8.0x
ROE·
Gross mgn35%
Net mgn-30%
Debt/EBITDA0.0x
Pillars2/3

Transparent value + quality ranking, distinct from the insider signal.

Financial data

as of FY 2025

FY ended December 2025 · cache

HK$3.26
Analyst consensus
·
Income statement
RevenueHK$1.3B
Gross profitHK$435.1M35% margin
EBITDAHK$78.2M6% margin
Net income-HK$379.7M-54.0% margin
Valuation
P/Book0.6x
Balance sheet & cash
Market capHK$658.5M
Total debtHK$3.4M
Free Cash FlowHK$81.4M
Debt / Equity0%
Profitability & ownership
ROA-2.0%
% insiders55.8%
% institutions14.5%
Last declaration on 7 July 2026
Declarations3 total
  • ▲
    DirectorExecutives
    27M HKD26HKEX
    2,921,000 shares@ HK$9.30323.18% mcap36.9% of flowShareXHKGHKEX:DA20260706E00750
    Canonical exit: 1 Oct 2026 (T+90)
  • ▲
    DirectorExecutives
    30M HKD26HKEX
    2,972,000 shares@ HK$10.05853.49% mcap40.6% of flowShareXHKGHKEX:DA20260706E00749
    Canonical exit: 30 Sept 2026 (T+90)
  • ▲
    DirectorExecutives
    17M HKD22HKEX
    1,340,000 shares@ HK$12.31421.93% mcap22.4% of flowShareXHKGHKEX:DA20260706E00747
    Canonical exit: 28 Sept 2026 (T+90)

3 of 3 declarations

About QingSong Health Corporation

QingSong Health Corporation is a company listed on the Hong Kong Stock Exchange, specializing in the healthcare sector. It focuses on the development and provision of innovative health solutions.